OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis
Ana Lleò, Christopher L. Bowlus, Guo–Xiang Yang, et al.
Hepatology (2010) Vol. 52, Iss. 3, pp. 987-998
Open Access | Times Cited: 205

Showing 1-25 of 205 citing articles:

Human autoimmune diseases: a comprehensive update
Lifeng Wang, Fu‐Sheng Wang, M. Eric Gershwin
Journal of Internal Medicine (2015) Vol. 278, Iss. 4, pp. 369-395
Open Access | Times Cited: 943

Primary biliary cirrhosis
Carlo Selmi, Christopher L. Bowlus, M. Eric Gershwin, et al.
The Lancet (2011) Vol. 377, Iss. 9777, pp. 1600-1609
Closed Access | Times Cited: 312

A biliary HCO3umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes
Simon Hohenester, Lucas J. Maillette de Buy Wenniger, Coen C. Paulusma, et al.
Hepatology (2011) Vol. 55, Iss. 1, pp. 173-183
Closed Access | Times Cited: 288

The Immunobiology and Pathophysiology of Primary Biliary Cirrhosis
Gideon M. Hirschfield, M. Eric Gershwin
Annual Review of Pathology Mechanisms of Disease (2013) Vol. 8, Iss. 1, pp. 303-330
Closed Access | Times Cited: 286

The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review
Wentao Ma, Fei Gao, Kui Gu, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 283

Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches
Gideon M. Hirschfield, E. Jenny Heathcote, M. Eric Gershwin
Gastroenterology (2010) Vol. 139, Iss. 5, pp. 1481-1496
Open Access | Times Cited: 259

Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Aliya Gulamhusein, Gideon M. Hirschfield
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 2, pp. 93-110
Closed Access | Times Cited: 238

The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Peter J. Kahrilas, Guy E. Boeckxstaens
Gastroenterology (2013) Vol. 145, Iss. 5, pp. 954-965
Open Access | Times Cited: 213

Primary biliary cholangitis
Ana Lleò, Giu-Qiang Wang, M. Eric Gershwin, et al.
The Lancet (2020) Vol. 396, Iss. 10266, pp. 1915-1926
Closed Access | Times Cited: 178

New Treatment Paradigms in Primary Biliary Cholangitis
Cynthia Levy, Michael P. Manns, Gideon M. Hirschfield
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2076-2087
Closed Access | Times Cited: 52

Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications
Marcelo G. Roma, Flavia D. Toledo, Andrea C. Boaglio, et al.
Clinical Science (2011) Vol. 121, Iss. 12, pp. 523-544
Open Access | Times Cited: 186

Liver Immunology
Dimitrios P. Bogdanos, Bin Gao, M. Eric Gershwin
Comprehensive physiology (2013), pp. 567-598
Open Access | Times Cited: 179

Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’
Ulrich Beuers, M. Eric Gershwin, Robert G. Gish, et al.
Hepatology (2015) Vol. 62, Iss. 5, pp. 1620-1622
Closed Access | Times Cited: 162

Mechanisms of environmental influence on human autoimmunity: A national institute of environmental health sciences expert panel workshop
Carlo Selmi, Patrick S.C. Leung, David H. Sherr, et al.
Journal of Autoimmunity (2012) Vol. 39, Iss. 4, pp. 272-284
Closed Access | Times Cited: 155

Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’
Ulrich Beuers, M. Eric Gershwin, Robert G. Gish, et al.
Gastroenterology (2015) Vol. 149, Iss. 6, pp. 1627-1629
Open Access | Times Cited: 150

Diagnosis and Management of Primary Biliary Cholangitis
Zobair M. Younossi, David Bernstein, Mitchell L. Shiffman, et al.
The American Journal of Gastroenterology (2018) Vol. 114, Iss. 1, pp. 48-63
Closed Access | Times Cited: 149

Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid
Masanobu Tsuda, Yuki Moritoki, Zhe-Xiong Lian, et al.
Hepatology (2011) Vol. 55, Iss. 2, pp. 512-521
Open Access | Times Cited: 142

Primary biliary cirrhosis and Sjögren’s syndrome: Autoimmune epithelitis
Carlo Selmi, Pier Luigi Meroni, M. Eric Gershwin
Journal of Autoimmunity (2011) Vol. 39, Iss. 1-2, pp. 34-42
Open Access | Times Cited: 135

Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis
Ana Lleò, Jieyue Liao, Pietro Invernizzi, et al.
Hepatology (2011) Vol. 55, Iss. 1, pp. 153-160
Open Access | Times Cited: 125

Hepatic Natural Killer Cells: Organ-Specific Sentinels of Liver Immune Homeostasis and Physiopathology
Joanna Mikulak, Elena Bruni, Ferdinando Oriolo, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 123

Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis
Shinji Shimoda, Kenichi Harada, Hiroaki Niiro, et al.
Hepatology (2011) Vol. 53, Iss. 4, pp. 1270-1281
Open Access | Times Cited: 119

Evaluation of indeterminate biliary strictures
Christopher L. Bowlus, Kristin Olson, M. Eric Gershwin
Nature Reviews Gastroenterology & Hepatology (2015) Vol. 13, Iss. 1, pp. 28-37
Closed Access | Times Cited: 111

The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review
Ana Lleò, Patrick S.C. Leung, Gideon M. Hirschfield, et al.
Seminars in Liver Disease (2019) Vol. 40, Iss. 01, pp. 034-048
Closed Access | Times Cited: 111

Current understanding of primary biliary cholangitis
Atsushi Tanaka
Clinical and Molecular Hepatology (2020) Vol. 27, Iss. 1, pp. 1-21
Open Access | Times Cited: 109

Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence
Alexie Bosch, Jérôme Dumortier, Delphine Maucort‐Boulch, et al.
Journal of Hepatology (2015) Vol. 63, Iss. 6, pp. 1449-1458
Closed Access | Times Cited: 108

Page 1 - Next Page

Scroll to top